Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact
NCT04665089
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Sepsis
Septic Shock
Immunoinflammatory Response
Interventions
DRUG:
Erythromycin
Sponsor
Tunis University